Greater Glasgow and Clyde Medicines

Latest Medicines Updates & News

Formulary Update (February 2022)

Posted: Monday, February 28, 2022

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary


VSL#3 & Vivomixx removed from Drug Tariff

Posted: Wednesday, February 16, 2022

Category - Medicines Update

Following a review by the Advisory Committee on Borderline Substances (ACBS) back in 2018, the probiotic food supplements VSL#3® and Vivomixx® were removed from Part XV of the Drug Tariff in England. The Committee concluded that the evidence did not sufficiently demonstrate that the products are clinically effective.


TrakCare Referral to the Anticoagulation Service

Posted: Tuesday, February 1, 2022

Category - Medicines Update

Prior to discharge, a prescriber must refer all patients on, or to be commenced on warfarin (or acenocoumarol) to the Glasgow and Clyde Anticoagulation Service (GCAS).  This should be regardless of whether: 

  • Their anticoagulation is considered stable or not
  • They had an appointment arranged prior to admission